Your browser doesn't support javascript.
loading
Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV.
Brueckl, Wolfgang M; Reck, Martin; Rittmeyer, Achim; Kollmeier, Jens; Wesseler, Claas; Wiest, Gunther H; Christopoulos, Petros; Stenzinger, Albrecht; Tufman, Amanda; Hoffknecht, Petra; Ulm, Bernhard; Reich, Fabian; Ficker, Joachim H; Laack, Eckart.
Afiliação
  • Brueckl WM; Department of Respiratory Medicine, Allergology and Sleep Medicine/Nuernberg Lung Cancer Center, Nuernberg General Hospital, Nuremberg, Germany.
  • Reck M; Paracelsus Medical University Nuremberg, Nuremberg, Germany.
  • Rittmeyer A; Department of Thoracic Oncology, Airway Research Center North, German Center for Lung Research, Lung Clinic, Grosshansdorf, Germany.
  • Kollmeier J; Lungenfachklinik Immenhausen, Ambulanz für pneumologische Onkologie, Kassel, Germany.
  • Wesseler C; Helios Klinikum Emil von Behring, Lungenklinik Heckeshorn, Berlin, Germany.
  • Wiest GH; Asklepios Tumorzentrum Hamburg, Klinikum Harburg, Hamburg, Germany.
  • Christopoulos P; Asklepios Tumorzentrum Hamburg, Klinikum Harburg, Hamburg, Germany.
  • Stenzinger A; Thoraxklinik-Heidelberg gGmbH, Heidelberg, Germany.
  • Tufman A; Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hoffknecht P; German Cancer Consortium (DKTK), Partner Site Heidelberg, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ulm B; Medizinische Klinik V, Pneumologie, Klinikum der Universität München, Member of the German Center for Lung Research, CPC-M, Munich, Germany.
  • Reich F; Lungenzentrum Osnabrueck, Klinik für Thoraxonkologie, Franziskus-Hospital Harderberg, Georgsmarienhütte, Germany.
  • Ficker JH; Unabhängige statistische Beratung Bernhard Ulm, Munich, Germany.
  • Laack E; Department of Respiratory Medicine, Allergology and Sleep Medicine/Nuernberg Lung Cancer Center, Nuernberg General Hospital, Nuremberg, Germany.
Transl Lung Cancer Res ; 10(7): 3093-3105, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34430350

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article